Loading...

Amy Lovejoy

TitleAssociate Physician
InstitutionUniversity of California San Diego
DepartmentPediatrics
Address9500 Gilman Drive #0984
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Herrick NL, Geddis AE, Lovejoy AE, Kim J, Schiff D, Thornburg CD. A novel compound heterozygous form of severe protein C deficiency causing bleeding without purpura fulminans. Pediatr Blood Cancer. 2017 Nov; 64(11). PMID: 28485122.
      View in: PubMed
    2. Lyle CA, Gibson E, Lovejoy AE, Goldenberg NA. Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study. Thromb Res. 2013 Jan; 131(1):37-41. PMID: 23195142.
      View in: PubMed
    3. Lovejoy AE, Bush RA, Pong AL, Hilfiker ML. A male adolescent with left iliac thrombophlebitis and heterozygosity for factor V Leiden mutation. J Pediatr Surg. 2009 Aug; 44(8):1640-2. PMID: 19635319.
      View in: PubMed
    4. Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography. Blood Coagul Fibrinolysis. 2007 Sep; 18(6):547-53. PMID: 17762530.
      View in: PubMed
    5. Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation. Blood Coagul Fibrinolysis. 2007 Mar; 18(2):97-103. PMID: 17287624.
      View in: PubMed
    6. Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood. 2006 Jul 01; 108(1):57-62. PMID: 16556896.
      View in: PubMed
    Amy's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _